Neogen (NEOG) Cash & Equivalents (2010 - 2026)
Neogen (NEOG) posted quarterly Cash & Equivalents of $185.5 million for Q2 2026, up 43.8% year-over-year from $129.0 million in Q2 2025, and up 16.01% quarter-over-quarter from $159.9 million in Q1 2026.
Neogen (NEOG) Cash & Equivalents (2010 - 2026) Analysis & Trends
Neogen's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $185.5 million for Q2 2026.
- In Q2 2026, Cash & Equivalents rose 43.8% year-over-year to $185.5 million; the TTM figure through May 2026 stood at $185.5 million (up 43.8% YoY), while the FY2026 annual figure was $185.5 million, up 43.8% from the prior year.
- Cash & Equivalents for Q2 2026 stood at $185.5 million, up from $159.9 million in the prior quarter.
- The five-year high for Cash & Equivalents was $205.8 million in Q4 2023, with the low at $42.9 million in Q1 2022.
- The 5-year median for Cash & Equivalents is $139.6 million (2024), against an average of $132.7 million.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents tumbled 41.65% in 2022, then soared 267.05% in 2023.
- Neogen's Cash & Equivalents stood at $100.0 million in 2022, then surged by 105.76% to $205.8 million in 2023, then slumped by 31.85% to $140.2 million in 2024, then advanced by 3.64% to $145.3 million in 2025, then gained by 27.63% to $185.5 million in 2026.
- Business Quant data shows NEOG's Cash & Equivalents at $185.5 million in Q2 2026, $159.9 million in Q1 2026, and $145.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Neogen | 2.59 Bn | 2.40 Bn | 107.80 Mn | 185.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 185.50 Mn |
| Feb 28, 2026 | 159.90 Mn |
| Nov 30, 2025 | 145.34 Mn |
| Aug 31, 2025 | 138.88 Mn |
| May 31, 2025 | 129.00 Mn |
| Feb 28, 2025 | 127.71 Mn |
| Nov 30, 2024 | 140.23 Mn |
| Aug 31, 2024 | 120.48 Mn |
| May 31, 2024 | 170.61 Mn |
| Feb 29, 2024 | 161.44 Mn |
| Nov 30, 2023 | 205.77 Mn |
| Aug 31, 2023 | 178.83 Mn |
| May 31, 2023 | 163.24 Mn |
| Feb 28, 2023 | 67.13 Mn |
| Nov 30, 2022 | 100.00 Mn |
| Aug 31, 2022 | 107.10 Mn |
| May 31, 2022 | 44.47 Mn |
| Feb 28, 2022 | 42.88 Mn |
| Nov 30, 2021 | 51.12 Mn |
| Aug 31, 2021 | 71.28 Mn |